{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:11:45Z","timestamp":1787897505878,"version":"build-2784847793"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\n\nBackground\n<\/jats:title>\nTuberculosis elimination requires implementation of multi-pronged, complex interventions, but there is limited understanding of frameworks for guiding implementation. Our aim was to explore the feasibility of applying multipronged package of TB elimination interventions guided using the Medical Research Council (MRC) framework.<\/jats:p>\n<\/jats:sec>\n\n\nMethods\n<\/jats:title>\nThis study is a component of a larger quasi-experimental study aimed at demonstrating what TB elimination interventions would entail under routine TB program conditions titled Demonstrating Multipronged and Optimized Novel Strategies to Reinforce Actions Targeted at Eliminating Tuberculosis.<\/jats:italic> During its preparatory phase in February 2023, we employed a participatory action research design which involved gathering feedback and insights from TB program managers, healthcare workers and community representatives about the study interventions. The study participants were selected from three districts of Amhara, Oromia, and Southern Nations, Nationalities and Peoples Regions of Ethiopia. Two senior researchers took detailed notes during the meetings using topic guided questions. Each topic guided question was thoroughly explored until no new issues emerged. Thematic analysis was conducted to summarize the reflections of the study participants from the three sessions conducted in the three regions.<\/jats:p>\n<\/jats:sec>\n\n\nResults\n<\/jats:title>\n108 participants attended the preparatory phase discussions which were summarized under five sub-themes under the main theme of \u201cLooking for local evidence compulsory for TB elimination<\/jats:italic>.\u201d These included; (1) the importance of community engagement which describes the need to include health extension workers, health development army, and other community structures to support the study, (2) government interest toward local evidence, which describes how local evidence is essential to support the TB program and address challenges, (3) homogeneity of officials\u2019 commitment across the regions which is reflected in their immense support to undertake the study and suggested working together for the study follow-up,(4) cross-cutting issues or multiple factors such as nutrition, sociocultural factors, livelihood, and housing, were considered, and (5) the importance of establishing TB treatment supporter, which describes the critical role that TB treatment supporters play in ensuring successful treatment outcomes.<\/jats:p>\n<\/jats:sec>\n\n\nConclusions\n<\/jats:title>\nThis study highlights the importance of MRC tailored protocol development and feasibility in effective implementation. Key lessons include the need for early stakeholder engagement, streamlined communication, and proactive risk management. Strong community engagement, government commitment, and addressing social determinants were critical to TB elimination. These findings emphasize the value of a collaborative, multi-pronged approach during the adoption and implementation of the TB elimination framework.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0318209","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:25:40Z","timestamp":1741627540000},"page":"e0318209","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Designing tuberculosis elimination framework through participatory processes in Ethiopia: Results from stakeholders\u2019 discussions"],"prefix":"10.1371","volume":"20","author":[{"given":"Mulatu","family":"Biru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Datiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degu","family":"Jerene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asfawesen G.","family":"Yohannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohannes","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9825-1761","authenticated-orcid":true,"given":"Pedro","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondmiu","family":"Gebrekiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewulsew","family":"Kassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2774-7628","authenticated-orcid":true,"given":"Zewdu G.","family":"Dememew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"pone.0318209.ref001","volume-title":"Global tuberculosis report 2023","year":"2023"},{"issue":"4","key":"pone.0318209.ref002","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijtb.2015.11.001","article-title":"WHO\u2019s end TB strategy: from stopping to ending the global TB epidemic","volume":"62","author":"M Uplekar","year":"2015","journal-title":"Indian J Tuberc"},{"key":"pone.0318209.ref003","volume-title":"Gear up to end TB: introducing the end TB strategy","author":"World Health Organization","year":"2015"},{"issue":"3","key":"pone.0318209.ref004","doi-asserted-by":"crossref","first-page":"e1001965","DOI":"10.1371\/journal.pmed.1001965","article-title":"Translational research for tuberculosis elimination: priorities, challenges, and actions","volume":"13","author":"C Lienhardt","year":"2016","journal-title":"PLoS Med"},{"key":"pone.0318209.ref005","volume-title":"Global tuberculosis report 2016","author":"World Health Organization","year":"2016"},{"key":"pone.0318209.ref006","first-page":"27060","article-title":"How urbanization affects the epidemiology of emerging infectious diseases","volume":"5","author":"C-J Neiderud","year":"2015","journal-title":"Infect Ecol Epidemiol"},{"issue":"1","key":"pone.0318209.ref007","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12889-020-8290-z","article-title":"High urban tuberculosis case notification rates can be misleading: evidence from an urban setting in Ethiopia","volume":"20","author":"D Datiko","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0318209.ref008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13063-018-3053-1","article-title":"Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II\/III, multicenter, randomized, open-label clinical trial","volume":"20","author":"M Lee","year":"2019","journal-title":"Trials"},{"issue":"1","key":"pone.0318209.ref009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00100-19","article-title":"Tuberculosis vaccine development: progress in clinical evaluation","volume":"33","author":"SB Sable","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"23","key":"pone.0318209.ref010","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0318209.ref011","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201712-2524OC","article-title":"Efficacy and safety of high-dose Rifampin in pulmonary tuberculosis. a randomized controlled trial","volume":"198","author":"GE Vel\u00e1squez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0318209.ref012","doi-asserted-by":"crossref","first-page":"146","DOI":"10.11604\/pamj.2022.43.146.35557","article-title":"Prospects for tuberculosis elimination in Ethiopia: feasibility, challenges, and opportunities","volume":"43","author":"TB Agizew","year":"2022","journal-title":"Pan Afr Med J"},{"issue":"5","key":"pone.0318209.ref013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2471\/BLT.19.243584","article-title":"Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial","volume":"98","author":"JJ Madan","year":"2020","journal-title":"Bullet World Health Organ"},{"issue":"1","key":"pone.0318209.ref014","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1186\/s12879-021-06833-x","article-title":"Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial","volume":"21","author":"AW Tadesse","year":"2021","journal-title":"BMC Infect Dis"},{"key":"pone.0318209.ref015","doi-asserted-by":"crossref","first-page":"n2061","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"K Skivington","year":"2021","journal-title":"BMJ"},{"key":"pone.0318209.ref016","volume-title":"Participatory action research in health care","author":"T Koch","year":"2009"},{"issue":"5","key":"pone.0318209.ref017","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jgf2.187","article-title":"Participatory research-A modernizing science for primary health care","volume":"19","author":"N Andersson","year":"2018","journal-title":"J Gen Fam Med"},{"issue":"2","key":"pone.0318209.ref018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1468-0009.2012.00665.x","article-title":"Uncovering the benefits of participatory research: implications of a realist review for health research and practice","volume":"90","author":"J Jagosh","year":"2012","journal-title":"Milbank Q"},{"key":"pone.0318209.ref019","volume-title":"Towards tuberculosis elimination: an action framework in low-incidence countries","author":"World Health Organization","year":"2014"},{"key":"pone.0318209.ref020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1146\/annurev-publhealth-040617-014128","article-title":"Selecting andimproving quasi-experimental designs in effectiveness and implementation research","volume":"39","author":"MA Handley","year":"2018","journal-title":"Ann Rev Public Health"},{"key":"pone.0318209.ref021","unstructured":"Kolko J. Sensemaking and framing: A theoretical reflection on perspective in design synthesis."},{"key":"pone.0318209.ref022","volume-title":"Transforming clinical research in the United States: challenges and opportunities: workshop summary","author":"RB Giffin"},{"key":"pone.0318209.ref023","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2023.03.008","article-title":"Community engagement in tuberculosis research: the EU-Patient-cEntric clinical tRial pLatforms (EU-PEARL) experience","volume":"130","author":"F Saluzzo","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"4","key":"pone.0318209.ref024","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5588\/pha.17.0036","article-title":"Enhancing tuberculosis patient detection and care through community volunteers in the urban poor, The Philippines","volume":"7","author":"A Querri","year":"2017","journal-title":"Public Health Action"},{"issue":"5","key":"pone.0318209.ref025","doi-asserted-by":"crossref","first-page":"e63174","DOI":"10.1371\/journal.pone.0063174","article-title":"Innovative community-based approaches doubled tuberculosis case notification and improve treatment outcome in Southern Ethiopia","volume":"8","author":"MA Yassin","year":"2013","journal-title":"PLoS ONE"},{"key":"pone.0318209.ref026","article-title":"The community as an active part in the implementation of interventions for the prevention and control of tuberculosis: a scoping review","author":"L Chavez-Rimache","year":"2023","journal-title":"medRxiv"},{"issue":"3","key":"pone.0318209.ref027","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/17441692.2014.880500","article-title":"Political commitment to tuberculosis control in Ghana","volume":"9","author":"J Amo-Adjei","year":"2014","journal-title":"Glob Public Health"},{"issue":"1","key":"pone.0318209.ref028","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijtb.2019.02.005","article-title":"The end TB strategy for India","volume":"66","author":"KS Sachdeva","year":"2019","journal-title":"Indian J Tubercul"},{"key":"pone.0318209.ref029","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1874279301810010037","article-title":"Type of treatment supporters in successful completion of tuberculosis treatment: A retrospective cohort study in Pakistan","volume":"10","author":"S Hussain","year":"2018","journal-title":"Open Infect Dis J"},{"issue":"3","key":"pone.0318209.ref030","first-page":"e22886","article-title":"Impact of treatment supporters on the treatment outcomes of drug resistant-tuberculosis (DR-TB) patients: A retrospective cohort study","volume":"14","author":"OP Giri","year":"2022","journal-title":"Cureus"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:26:03Z","timestamp":1741627563000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318209"}},"subtitle":[],"editor":[{"given":"Mohammed Hasen","family":"Badeso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0318209","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}